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The transcription factor Foxg1 regulates
telencephalic progenitor proliferation cell
autonomously, in part by controlling Pax6
expression levels
Martine N Manuel1*, Ben Martynoga1,2†, Mike D Molinek1†, Jane C Quinn1,3†, Corinne Kroemmer1,
John O Mason1, David J Price1
Abstract
Background: The transcription factor Foxg1 is an important regulator of telencephalic cell cycles. Its inactivation
causes premature lengthening of telencephalic progenitor cell cycles and increased neurogenic divisions, leading
to severe hypoplasia of the telencephalon. These proliferation defects could be a secondary consequence of the
loss of Foxg1 caused by the abnormal expression of several morphogens (Fibroblast growth factor 8, bone
morphogenetic proteins) in the telencephalon of Foxg1 null mutants. Here we investigated whether Foxg1 has a
cell autonomous role in the regulation of telencephalic progenitor proliferation. We analysed Foxg1+/+↔Foxg1-/-
chimeras, in which mutant telencephalic cells have the potential to interact with, and to have any cell non-
autonomous defects rescued by, normal wild-type cells.
Results: Our analysis showed that the Foxg1-/- cells are under-represented in the chimeric telencephalon and the
proportion of them in S-phase is significantly smaller than that of their wild-type neighbours, indicating that their
under-representation is caused by a cell autonomous reduction in their proliferation. We then analysed the
expression of the cell-cycle regulator Pax6 and found that it is cell-autonomously downregulated in Foxg1-/- dorsal
telencephalic cells. We went on to show that the introduction into Foxg1-/- embryos of a transgene designed to
reverse Pax6 expression defects resulted in a partial rescue of the telencephalic progenitor proliferation defects.
Conclusions: We conclude that Foxg1 exerts control over telencephalic progenitor proliferation by cell
autonomous mechanisms that include the regulation of Pax6, which itself is known to regulate proliferation cell
autonomously in a regional manner.
Background
Each part of the central nervous system attains a charac-
teristic size during embryogenesis. The vertebrate fore-
brain (prosencephalon) grows larger than other parts of
the neural tube, giving rise to rostral bilateral swellings
known as telencephalic vesicles or, when considered
together, the telencephalon. The telencephalon is parti-
cularly large in mammals and generates the cerebral cor-
tex and basal ganglia. The differential growth of each
part of the central nervous system depends critically on
region-specific regulation of neural cell proliferation in
the embryo. While there is extensive understanding of
effector molecules such as cell cycle proteins that control
the cell proliferation in general, we know much less
about the mechanisms that specify the different rates at
which cells divide in each part of the embryo.
The early neural plate and neural tube are patterned by
region-specific expression of transcription factors, some
of which exert control over cell proliferation as well as
other aspects of regional development. For two of these
transcription factors, Foxg1 and Pax6, there is strong evi-
dence that one of their primary functions is to regulate
telencephalic cell cycles [1-5]. Both are expressed in
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progenitors in the developing telencephalon, with Foxg1
being activated slightly before Pax6 [4,6,7].
Foxg1 is one of the earliest transcription factors expressed
specifically in the part of the neural plate that gives rise to
the telencephalon and it remains expressed throughout the
telencephalon during embryonic development. Its inactiva-
tion leads to severe telencephalic hypoplasia [4]. In a pre-
vious study we showed that the cell cycle lengthens
prematurely and neurogenic divisions are increased in
Foxg1-/- telencephalon, thereby reducing the pool of prolif-
erating progenitors [5]. These proliferation defects coincide
with reduced expression of the pro-proliferative morphogen
Fibroblast growth factor 8 (Fgf8) in the rostral telencephalon
and expanded expression of several bone morphogenetic
proteins (BMPs), which promote neural differentiation,
from their normally dorsally restricted domain [5,8-10].
These observations suggest two possible explanations for
the proliferation defects in Foxg1-/- telencephalon. First, it is
possible that the proliferation defects of Foxg1-/- telencepha-
lic progenitors are secondary to abnormal expression of
morphogens such as Fgf8 and BMPs. Second, telencephalic
progenitors might require Foxg1 cell autonomously for their
normal proliferation.
To test whether Foxg1 has a cell autonomous role in the
regulation of telencephalic progenitor proliferation, we
analysed Foxg1+/+↔Foxg1-/- chimeras, in which mutant
telencephalic cells have the potential to interact with, and
to have any cell non-autonomous defects rescued by, nor-
mal wild-type cells. We found that the Foxg1-/- cells were
under-represented in the chimeric telencephalon and that
the proportion of them in S-phase was significantly smal-
ler than that of their wild-type neighbours, indicating
that their under-representation was caused by a cell-
autonomous reduction in their proliferation.
We then examined the relationship between Foxg1 and
Pax6, in view of their overlapping expression patterns and
the fact that Pax6 is known to regulate cell autonomously
the proliferation of cortical progenitors [2,3]. We found
that Pax6 is cell-autonomously downregulated in Foxg1-/-
dorsal telencephalic cells. We tested the hypothesis that
this contributes to the proliferation defects in Foxg1-/-
embryos by introducing a transgene designed to reverse
Pax6 expression defects into Foxg1-/- embryos and found
that this partially rescued their telencephalic progenitor
proliferation defects.
Materials and methods
Animals
Animal care followed institutional guidelines and UK
Home Office regulations.
Derivation of Foxg1-/- embryonic stem cells
Wild-type (Foxg1+/+) or null-mutant (Foxg1cre/lacZ)
embryonic stem (ES) cells were derived using the
following protocol. Female mice (129Sv; Foxg1+/lacZ)
were superovulated by intraperitoneal (i.p.) injection of
5U pregnant mare’s serum gonadotrophin (Intervet,
Milton Keynes, UK) at the middle of the light cycle fol-
lowed 47 hours later by i.p. injection of 5U human chor-
ionic gonadotrophin (Intervet, UK). Females were mated
with Foxg1+/cre stud males homozygous for a reiterated
b-globin repeat transgene (Tg/Tg) [11]. Delayed implan-
tation was induced 2.5 days post-coitum by i.p. injection
of Tamoxifen (Sigma, Gillingham, UK; 10 μg/animal)
and subcutaneous injection of Depo-Provera (Sigma;
1 to 3 mg/animal). At 7.5 days post-coitum, blastocysts
were flushed from the uterus, transferred to a gelati-
nised well containing N2B27 medium with 10 ng/ml
leukaemia inhibitory factor and cultured at 37°C in 5%
CO2. After approximately 5 days, inner cell mass out-
growths were detached from the bottom of each well
using a fine pipette and disaggregated in trypsin (0.025%
for 2 to 3 minutes at 37°C) to give individual clusters of
1 to 5 cells. Clusters were transferred to a fresh gelati-
nised well containing N2B27 media containing leukae-
mia inhibitory factor (10 ng/ml) with the addition of
BMP4 (10 ng/ml). Primary ES cell colonies were visible
after approximately 5 days in culture. ES cell lines were
passaged in feeder-free conditions in BHK-21 Glasgow
MEM (GMEM) with 15% fetal bovine serum and leu-
kaemia inhibitory factor (1,000 U/ml). Cell lines were
genotyped for presence of cre, lacZ and Tg; their glucose
phosphate isomerase 1 (GPI1) isotype was confirmed as
described previously [2]. All ES cell lines used for chi-
mera generation were karyotyped and found to have a
normal chromosome complement.
Chimera production and tissue contribution analysis
Chimeras used for tissue contribution and proliferation
analyses were produced by injection of Foxg1cre/lacZ;Tg+
or Foxg1+/+;Tg+ ES cells into wild-type blastocysts. The
ES cells and blastocysts differed at the GPI1 locus. Chi-
meras were transferred to pseudopregnant females and
collected at E12.5. Chimeras were genotyped and the
global contribution of ES cell-derived embryonic tissue
was estimated using GPI1 electrophoresis as described
previously [12]. Tg+ cells were visualized in coronal wax
sections of the head (8 μm) by DNA-DNA in situ hybri-
disation [13,14]. StereoInvestigator™ (MBF Bioscience,
Williston, Vermont, USA) was used to analyse the con-
tribution of Tg+ cells: the hippocampus, cortex, ventral
telencephalon and dorsal thalamus were delineated and
counting boxes of 150 × 150 μm randomly assigned
according to the programme’s parameters. Three wild-
type chimeras (30%, 37%, 40% GPI1A) and three mutant
chimeras (12%, 14% and 14% GPI1A) were analysed.
Chimeras used for Pax6 expression analysis were pro-
duced by the aggregation of preimplantation embryos as
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described in Manuel et al., 2010. Foxg1cre/lacz and
Foxg1+/lacZ embryos were aggregated with Foxg1+/+
embryos to give experimental and control chimeras,
respectively. In these cases, the mutant cells were recog-
nizable because the coding sequence of one Foxg1 allele
is replaced by a lacZ reporter cassette [4].
Elevating Pax6 levels in Foxg1-/- embryos
The Pax77 transgene [15] was crossed into Foxg1-/-
embryos to increase their Pax6 levels. This transgene
comprises five to seven copies of the human PAX6 locus
including its upstream and downstream regulatory
regions. Our previous studies showed that wild-type
mice carrying the Pax77 transgene display elevated Pax6
levels at all its sites of expression [3,16].
Proliferation analyses
Pregnant females at E12.5 were sacrificed 30 minutes
after injection with 200 μl of 10 mg/ml bromodeoxyuri-
dine (BrdU; Sigma; in 0.9% NaCl, i.p.). For analysis of
proliferation in chimeras, wax coronal sections were
immunostained with anti-BrdU following b-globin
DNA-DNA in situ hybridization. The percentage of Tg+
(that is, mutant) progenitors in S-phase was determined
by counting the total number of BrdU+ Tg+ cells and
BrdU- Tg+ cells in the ventricular zone of the dorsal and
ventral telencephalon of chimeras. To determine the
percentage of Tg- (that is, wild-type) progenitors in
S-phase, BrdU+ Tg- and BrdU- Tg- cells were counted in
100-μm-wide sampling boxes in the ventricular zone of
the dorsal and ventral telencephalon of chimeras.
For analysis of the effects of Pax6 overexpression on
proliferation, BrdU+ and BrdU- cells were counted in
100-μm-wide sampling boxes along the ventricular zone
of the dorsal telencephalon of wild-type embryos and
the whole telencephalon of Foxg1-/- and Foxg1-/-;Pax77
embryos at rostral, central and caudal levels. Each count
was repeated on three to five non-adjacent sections
from each embryo (n = 3 embryos of each genotype).
Quantitative reverse transcription-PCR
RNA was extracted from the telencephalon of Foxg1-/-
and Foxg1-/-;Pax77 littermates at E12.5 using Qiagen
Rneasy kit (Qiagen, Crawley, UK). cDNA synthesis was
performed as described in [17]. Analysis of total Pax6
levels by quantitative PCR was performed as described
in [16].
Immunohistochemistry
Immunohistochemistry was carried out as described pre-
viously [5]. The primary antibodies used were: anti-Pax6
(1:50 to 1:500; Developmental Studies Hybridoma Bank);
anti-b-galactosidase (b-gal; 1:800; Invitrogen, Paisley, UK);
and anti-BrdU (1:200; Becton Dickinson, Oxford, UK).
In situ hybridisation
Antisense RNA probes for Emx1 and Emx2 were digoxi-
genin labelled. In situ hybridisations were on 10-μm
paraffin sections [18].
Results
Foxg1 is required cell-autonomously for normal
telencephalic progenitor proliferation
To test the hypothesis that Foxg1 is required cell autono-
mously for cells to contribute normally to the telence-
phalon, we made experimental and control chimeras by
injecting Foxg1-/- or Foxg1+/+ ES cells into wild-type blas-
tocysts. Foxg1-/- and Foxg1+/+ ES-derived cells carried a
b-globin transgene (Tg) identifiable by DNA in situ hybri-
dization, which generated a labelled spot in their nuclei
(Figure 1A-D). In each chimeric embryo, an estimate
of the percentage of ES-derived cells in Foxg1 non-
expressing regions was obtained by quantitative analysis
of the GPI1 isozyme composition of the upper body [12].
ES cells produced the GPI1A isozyme, and so the percen-
tage of GPI1 that was GPI1A in the upper body repre-
sented the contribution of the ES-derived cells to regions
of the embryo where the presence or absence of Foxg1
was predicted to have no effect.
We analysed three experimental and three control chi-
meras at E12.5 and determined the percentage of Tg+
cells in the hippocampus, the cortex and the ventral tel-
encephalon. The dorsal thalamus, in which Foxg1 is not
normally expressed, was used as a control brain region.
For each of these tissues in each chimera, the observed
contribution of Tg+ cells (obsTg+) was divided by the
expected contribution of Tg+ cells (expTg+) given by the
percentage of GPI1A for that chimera. In control chi-
meras and in the dorsal thalamus of experimental chi-
meras the obsTg+:expTg+ ratios were close to 1, which
is the value anticipated in tissues where the contribution
of ES-derived cells is no different to that throughout the
body of the embryo. Foxg1-/- Tg+ cells were present
throughout the telencephalon of experimental chimeras,
but they were significantly under-represented
(Figure 1E). The degree of under-representation was
similar in all three tissues studied, that is, the hippocam-
pus, the cortex and the ventral telencephalon.
We then tested whether the under-representation of
Foxg1-/- cells in the telencephalon of chimeras was likely
due to a cell autonomous proliferation defect using BrdU
to label telencephalic progenitors in S-phase of the cell
cycle. In the telencephalic ventricular zone of experimental
chimeras, percentages of Foxg1-/- cells that were BrdU+
were about half those of surrounding Foxg1+/+ cells that
were BrdU+. The reductions were similar in dorsal and
ventral regions (Figure 2A,B). In the dorsal thalamus
(Foxg1 non-expressing control tissue), the percentage
of Foxg1-/- progenitors in S-phase was equal to that of
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Figure 1 Foxg1-/-mutant cells are underrepresented in the telencephalon of Foxg1+/+;Tg-↔Foxg1-/-;Tg+chimeras. (A-D) Coronal sections
through the thalamus (A,B) and the ventral telencephalon (C,D) of E12.5 Foxg1+/+;Tg-↔Foxg1+/+;Tg+ control (A,C) and Foxg1+/+;Tg-↔Foxg1-/-;Tg+
experimental chimeras (B,D) showing Tg+ cells (labelled with dark dots) derived from the ES cells. (D) Very few Tg+ cells (arrowheads) are observed in
the ventral telencephalon of experimental chimeras. Scale bar: 50 μm. (E) Ratios of observed/expected contributions of Tg+ cells in the dorsal
thalamus, the hippocampus, the cortex and the ventral telencephalon of control (Foxg1+/+;Tg-↔Foxg1+/+;Tg+) and experimental (Foxg1+/+;Tg-↔Foxg1-/-;
Tg+) chimeras. Tg+ cells are significantly underrepresented in the telencephalon of mutant chimeras (mean ± s.e.m, n = 3 embryos of each genotype;
Student’s t-test, P < 0.05).
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Figure 2 Foxg1-/- cells display a cell autonomous proliferation defect. (A) Coronal section through the telencephalon of an E12.5 Foxg1+/+;
Tg-↔Foxg1-/-;Tg+ chimera showing Tg+ cells (labelled with dark dots) and BrdU+ cells (with brown nuclei). Clusters of BrdU- Tg+ cells are present
among BrdU+ Tg- and Tg+ progenitors. Scale bar: 50 μm. (B) Percentages of Tg+ cells in S-phase in the dorsal and ventral telencephalon, but not
the dorsal thalamus, of experimental chimeras are significantly lower than the percentages of Tg- cells in S-phase (mean ± s.e.m, n = 3 embryos
of each genotype; Student’s t-test, P < 0.05).
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Foxg1+/+ progenitors. These results indicate that Foxg1 is
required cell autonomously for normal proliferation of tel-
encephalic progenitors.
Foxg1 is required cell autonomously for normal
telencephalic Pax6 expression
We examined the relationship between Foxg1 and the
transcription factor Pax6, which is known to regulate tele-
ncephalic progenitor proliferation and whose telencephalic
expression begins shortly after that of Foxg1 [1-3,6,19,20].
Expression of Pax6 is normally restricted to dorsal telence-
phalon. In Foxg1-/- embryos, progenitors throughout the
entire telencephalon express Pax6 [4,5,21] and previous
work has shown that this reflects the inability of Foxg1-/-
telencephalic cells to develop ventral telencephalic fates
[21]. Here, we examined the levels of expression of Pax6 in
the telencephalon of Foxg1-/- embryos and in chimeras.
Immunofluorescence for Pax6 showed that, whereas Pax6
is expressed in a rostro-lateralhigh to caudo-mediallow gradi-
ent in the dorsal telencephalon in wild-type embryos and
control chimeras (Figure 3A,C), in Foxg1-/- embryos there
is no obvious gradient and Pax6 appears to be expressed at
a lower level throughout the telencephalon (Figure 3B).
Comparison of Figure 3A and 3B shows a normal level of
immunostaining in the Foxg1-/- prethalamus and eminentia
thalami, a region that does not express Foxg1 and should
not be affected in mutants, but comparatively lower immu-
nostaining of the lateral telencephalon.
Regional reduction in immunostaining for Pax6 was very
obvious in Foxg1-/- cells in Foxg1+/+ ↔ Foxg1-/- chimeras.
In rostro-lateral regions of the dorsal telencephalon of
experimental chimeras, even very small groups of Foxg1-/-
cells (recognized by their expression of b-gal) expressed
Pax6 at discernibly lower levels than their neighbours
(Figure 3H-J). In more medial positions in the dorsal tele-
ncephalon of experimental chimeras, where Pax6 levels
are lower in Foxg1+/+ cells, Foxg1-/- cells appeared to
express Pax6 at similar levels to their neighbouring
Foxg1+/+ cells (Figure 3K-M). In control chimeras, levels
of Pax6 immunostaining in b-gal-expressing cells and
their neighbours were similar (Figure 3D-F). In summary,
Foxg1-/- cells express Pax6 at low levels, similar to those
normally found in caudo-medial telencephalon, through
all parts of the telencephalon with no increase in levels in
rostro-lateral regions. Our findings from chimeras indicate
that the generation of the normal graded increase of Pax6
in the rostro-lateral part of the dorsal telencephalon
requires Foxg1 cell-autonomously.
Pax6 downregulation contributes to the proliferation
defects of Foxg1-/- telencephalic progenitors
As Pax6 is implicated in the control of cortical progeni-
tor proliferation [1-3,19,20,22,23], we hypothesised that
Foxg1 might regulate telencephalic cell proliferation, at
least in part, via its regulation of Pax6 levels. The cell
autonomous inability of many Foxg1-/- dorsal telence-
phalic cells to achieve normal Pax6 levels might contri-
bute to their proliferation defects. To distinguish
between this possibility and an alternative scenario in
which loss of Foxg1 prevents normal proliferation inde-
pendently of any change in Pax6 levels, we generated
mice lacking Foxg1 but with elevated Pax6 levels. To do
this, we used the Pax6 overexpressing line, Pax77, in
which Pax6 levels are elevated within the physiological
range in the normal domains of expression of Pax6
[3,15,16].
To confirm that this method successfully increased
overall expression in Foxg1-/- mutants, we compared the
levels of Pax6 mRNA in the telencephalon of Foxg1-/-
and Foxg1-/-;Pax77+ embryos at E12.5 by quantitative
RT-PCR. We found that levels were increased about
2.25-fold in the telencephalon of Foxg1-/-;Pax77+
embryos compared to Foxg1-/- embryos (Figure 4A; Stu-
dent’s t-test, P < 0.05). This is a similar increase to that
found when the Pax77 transgene is expressed on a wild-
type background [16].
With immunohistochemistry, we observed more
intense Pax6 labelling throughout the telencephalon in
Foxg1-/-;Pax77+ embryos (Figure 4C) than in Foxg1-/-
embryos (Figure 4B). Whereas in Foxg1-/- embryos Pax6
immunostaining was much weaker throughout the tele-
ncephalon than in the prethalamus and eminentia tha-
lami, in Foxg1-/-;Pax77+ embryos the intensity of staining
in these regions was similar (Figure 4B,C). Pax6 immuno-
labelling was increased across the telencephalon with no
evidence for the restoration of a normal lateralhigh to
mediallow (Figure 4B,C) and rostralhigh to caudallow (not
shown) gradient of expression, indicating that the Pax77
transgene and the endogenous Pax6 locus were
being regulated similarly to each other on a Foxg1-/-
background.
As shown in Figures 4B,C, the morphology of the
Foxg1-/-;Pax77+ telencephalon retained its overall resem-
blance to the Foxg1-/- telencephalon at E12.5, with no
restoration of ventral telencephalic structure. This is not
surprising since previous work has shown that mechan-
isms independent of Pax6 mediate Foxg1’s actions in gen-
erating ventral telencephalon [21]. To test whether
increased levels of Pax6 countered the proliferation defects
in the Foxg1 mutant telencephalon, we used BrdU to label
telencephalic progenitors in S-phase of the cell cycle. We
determined percentages of ventricular zone cells in S-
phase (referred to as the labelling indices) in a set of sam-
pling boxes (placed as shown in Figure 5A,B) through the
dorsal telencephalon of wild-type embryos (Figure 5A)
and through the telencephalon of Foxg1-/- and Foxg1-/-;
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Figure 3 Pax6 is misregulated in Foxg1-/- cells. (A,B) Pax6 immunofluorescence on coronal sections through the telencephalon of wild-type
(wt) (A) and Foxg1-/- (B) embryos at E12.5. The characteristic lateralhigh to mediallow gradient of Pax6 expression in the telencephalon is observed
in wild-type (A) but not in mutant embryos (C). (C,G) Pax6 immunofluorescence on coronal sections through the telencephalon of a Foxg1
+/+↔Foxg1+/- (C) control chimera and a Foxg1+/+↔Foxg1-/-experimental chimera (G). (D-F,H-J,K-M) Selected regions are shown at higher
magnification and co-labelled for b-gal expressed by Foxg1+/- (D-F) or Foxg1-/- cells (H-J,K-M). Throughout the whole telencephalon of control
chimeras (D-F) and the dorso-medial telencephalon of experimental chimeras (K-M), b-gal+ cells (arrows) express Pax6 at levels indistinguishable
from those in adjacent b-gal- cells. In the dorso-lateral telencephalon of experimental chimeras (H-J), however, Foxg1-/- (b-gal+) cells display
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Pax77 embryos (Figure 5B) at E12.5 at three levels:
(i) rostral (normally Pax6high): (ii) central; and (iii) caudal
(normally Pax6low) levels.
Consistent with previous studies [4,5], we found that
the average labelling index was significantly lower in the
Foxg1-/- telencephalon than in the wild-type telencepha-
lon at all three rostro-caudal levels (Figure 5C). At ros-
tral and central levels, average labelling indices were
significantly increased in Foxg1-/-;Pax77+ telencephalon
compared to Foxg1-/- telencephalon, although they were
not restored completely to wild-type levels (Figure 5C).
Caudally, the labelling index was not significantly differ-
ent in Foxg1-/-;Pax77+ compared to Foxg1-/- telencepha-
lon. At rostral, central and caudal levels, labelling
indices were similar from dorsal to ventral in the wild-
type, Foxg1-/- and Foxg1-/-;Pax77+ telencephalon and in
Foxg1-/- ; Pax77Foxg1-/-
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Figure 4 Pax6 expression levels are increased in Foxg1-/-;Pax77 telencephalon compared to Foxg1-/-telencephalon. (A) Levels of total
Pax6 mRNA (endogenous Pax6 and human PAX6) in the telencephalon of E12.5 Foxg1-/-;Pax77 embryos and Foxg1-/- embryos determined by
real-time quantitative RT-PCR and normalised against GAPDH mRNA levels (mean ± s.e.m, n = 3 in each case). Total Pax6 mRNA levels are
significantly increased in Foxg1-/-;Pax77 telencephalon compared to Foxg1-/- telencephalon (Student’s t-test, P < 0.05). (B,C) Coronal sections
through one hemisphere of the forebrain of Foxg1-/- (B) and Foxg1-/-;Pax77 (C) embryos at E12.5, showing the expression of total Pax6
(endogenous Pax6 and human PAX6). Pax6 levels appear increased in Foxg1-/-;Pax77 compared to Foxg1-/- telencephalon, although the lateralhigh
to mediallow gradient is not restored.
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the wild-type dorsal telencephalon and so data from all
dorsal to ventral sampling areas were combined for each
genotype to generate the histograms in Figure 5C.
We conclude that raising Pax6 levels throughout the
telencephalon of Foxg1-/- embryos raises proliferation
rates in the direction of normal in rostral and central
parts of the telencephalon. It does not, however, have a
detectable effect in caudal telencephalon.
It is possible that Foxg1 and/or Pax6 directly regulate
the expression of genes that regulate proliferation, such
as cell cycle genes. Alternatively, they might affect
proliferation indirectly by controlling the expression of
other transcription factors that themselves regulate prolif-
eration. Previous work has shown that Emx1 and Emx2,
two transcription factors implicated in the control of corti-
cal progenitor proliferation [24], are misregulated in the
Foxg1-/- telencephalon [25]. Whereas Emx1 and Emx2 are
expressed in a rostro-laterallow to caudo-medialhigh gradi-
ent in the dorsal telencephalon in wild-type embryos [25]
(Figure 6A,D), in Foxg1-/- embryos there is no obvious gra-
dient and they appear to be expressed at a high level
throughout the telencephalon [25] (Figure 6B,E). Since an
% Brdu+ cells
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Figure 5 Proliferation defects are reversed in Foxg1-/-telencephalon if Pax6 levels are increased. (A,B) Coronal sections through the
telencephalon of a wild-type (A) and a Foxg1-/- embryo (B) at E12.5 labelled with anti-BrDU (brown). Boxes 100 μm wide show the positions
sampled in the wild-type dorsal telencephalon (A) and the whole telencephalon of embryos lacking Foxg1 (B). (C) Percentages of cells in S-
phase are significantly lower in the Foxg1-/- telencephalon compared to the wild-type at rostral, central and caudal levels (mean ± s.e.m. In all
three regions: wild-type, n = 3; Foxg1-/-, n = 4; Student’s t-test, P < 0.01). In Foxg1-/-;Pax77 embryos, percentages of cells in S-phase are
significantly increased compared to those in Foxg1-/- embryos at rostral (mean ± s.e.m, n = 4; Student’s t-test, P < 0.05) and central (mean ± s.e.
m, n = 4; Student’s t-test, P < 0.01) but not at caudal levels.
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earlier study implicated Pax6 as a regulator of Emx1 and
Emx2 expression [26], we wondered whether the observed
rise in proliferation rate in the rostral and central telence-
phalon of Foxg1-/-;Pax77 embryos might result from a
restoration of normal Emx1 and Emx2 expression. In situ
hybridisation for Emx1 and Emx2 expression in the tele-
ncephalon of Foxg1-/-;Pax77 embryos (Figure 6C,F) did
not show any obvious change compared to Foxg1-/-
mutants (Figure 6B,E). It is unlikely, therefore, that elevat-
ing Pax6 levels affects proliferation via a change in Emx1
or Emx2 expression.
Discussion
Foxg1 and Pax6 are transcription factors essential for
early brain development and are implicated particularly
strongly in the regulation of telencephalic progenitor
proliferation [1-5]. Here we provide evidence linking the
activities of the two factors in the regulation of progeni-
tor proliferation. We show that Foxg1 regulates cell
autonomously both proliferation and levels of Pax6
expression in telencephalic progenitors. Pax6 is itself
already known to regulate telencephalic cell proliferation
by cell autonomous mechanisms [2,3]. We show that
raising Pax6 levels in Foxg1-/- embryos partially reverses
their telencephalic proliferation defects. This suggests
that reduced proliferation in Foxg1-/- telencephalic pro-
genitors can be explained, at least in part, by their
reduced Pax6 levels.
Our evidence that Foxg1 regulates cell proliferation cell
autonomously is based on data from chimeras in which
the proportions of mutant cells are relatively low even in
areas that do not normally express Foxg1. The advantage
of the mutant cells being greatly outnumbered by the
wild-type cells is that it increases the probability of rescu-
ing any cell non-autonomous defects that they might
have in Foxg1-/- telencephalon, arising, for example, from
altered production of intercellular signals such as Fgf8 or
BMPs by surrounding cells [5,8-10]. In chimeras, the
labelling indices of mutant telencephalic cells (that is, the
percentages of mutant cells in S-phase of the cell cycle)
were around 30% (Figure 2B), which is the same as the
labelling indices of mutant cells in full Foxg1-/- mutants
(Figure 5C). This means that the proliferative defects of
Foxg1-/- cells might be accounted for entirely by cell
autonomous defects, but it does not exclude the possibi-
lity that cell non-autonomous proliferation-enhancing
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Figure 6 Increased Pax6 levels do not restore normal Emx1 and Emx2 expression in the telencephalon of Foxg1 mutant embryos. (A-F)
In situ hybridisation for Emx1 (A-C) and Emx2 (D-F) on coronal sections through the telencephalon of wild-type (wt) (A,D), Foxg1-/- (B,E) and
Foxg1-/-;Pax77 (C,F) E12.5 embryos. Scale bar: 100 μm.
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processes such as intercellular signalling are defective in
full Foxg1-/- mutants.
When examined in detail, the relationship between
Foxg1 and Pax6 is not straightforward. Interestingly,
while loss of Foxg1 lowers overall Pax6 expression in
the telencephalon, the magnitude of the effect is regio-
nal: the greatest reduction is in those areas where Pax6
expression is normally highest, that is, rostro-laterally.
The consequence is to abolish the normal gradient of
expression of Pax6 across the telencephalon. Since in
normal telencephalon Foxg1 expression levels are not
linearly related to Pax6 expression levels - for example,
Foxg1 is normally expressed in some ventral regions
where Pax6 is not [4,7] - it seems most likely that Foxg1
is an essential requirement for activation of normal tele-
ncephalic Pax6 expression in combination with addi-
tional factors. Together these factors might activate
Pax6 expression and raise its levels rostro-laterally;
Foxg1 is a required component in this process and its
loss causes Pax6 expression to fall to basal levels nor-
mally found caudo-medially.
The ideal rescue experiment would have involved
reactivation of the graded expression of Pax6 across the
telencephalon in a Foxg1-/- embryo. This is, however,
not feasible with existing tools. Our approach increased
Pax6 levels in Foxg1-/- telencephalon in a controlled
manner within a physiological range but did not restore
the gradient of expression. Immunohistochemistry
suggested that levels were raised throughout the telence-
phalon to those normally seen in the lateral telencepha-
lon, prethalamus and eminentia thalami. Interestingly,
while this raised overall proliferation rates in the
Foxg1-/- telencephalon, effects were again regional with
the greatest rescue seen rostrally, coinciding with the
region where Pax6 is normally highest [7].
Previous studies have shown that normal levels of
Pax6 are particularly important for regulating prolifera-
tion in the rostral part of the telencephalon where Pax6
levels are normally highest [3,19]. The simplest explana-
tion for the failure of caudal telencephalic progenitors
to increase their proliferation in response to elevation of
Pax6 levels is that they are not competent to respond to
this increase and their proliferation is regulated mainly
by Foxg1-dependent factors other than Pax6.
Even rostrally, elevation of Pax6 levels in Foxg1-/- tele-
ncephalon did not restore normal proliferation. There
are several possible explanations for this. Probably the
best is that Foxg1 regulates telencephalic progenitor
proliferation through pathways that do not involve Pax6
as well as through pathways that do involve Pax6. The
Pax6-independent pathways might be cell autonomous
or cell non-autonomous. While our chimera experi-
ments provide clear evidence that Foxg1 regulates cell
proliferation cell autonomously, they do not exclude the
possibility of cell non-autonomous defects with the
potential to influence telencephalic progenitor prolifera-
tion in Foxg1-/- embryos. It is known, for example, that
Foxg1-/- embryos have reduced expression of the pro-
proliferative intercellular signalling molecule Fgf8 [5].
Cell autonomous actions of Foxg1 might include direct
regulation of the transcription of cell cycle genes in tele-
ncephalic progenitors but there is currently little evi-
dence on which to base strong hypotheses. For example,
while previous studies have shown that Foxg1 can inhi-
bit TGF-beta-mediated anti-proliferative responses
through suppressing p21 transcription and P21 is
expressed in an expanded domain in Foxg1 mutants, we
have shown previously that P21 is not upregulated in
Foxg1-/- telencephalic cells in chimeras [21].
Conclusions
In their original description of the functions of Foxg1,
Xuan et al. [4] described a major proliferation defect as
the most prominent feature of the Foxg1-/- phenotype.
Subsequent work has reinforced this conclusion and has
added important information on the importance of
Foxg1 for normal development of telencephalic dorso-
ventral structures [5,21,27]. Here we focussed on the
gene’s pro-proliferative function. We conclude that
Foxg1 exerts control over telencephalic progenitor pro-
liferation by cell autonomous mechanisms that include
the regulation of Pax6, which itself regulates prolifera-
tion cell autonomously in a regional manner.
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